查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1860304

立体定位手术设备市场：2025-2032年全球预测（按最终用户、技术、产品、类型和应用划分）

Stereotactic Surgery Devices Market by End User, Technology, Product, Type, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，立体定位手术设备市场将成长至 406.5 亿美元，复合年增长率为 5.50%。

关键市场统计数据
基准年 2024 264.7亿美元
预计年份：2025年 279.6亿美元
预测年份 2032 406.5亿美元
复合年增长率 (%) 5.50%

高精度导航、整合影像工作流程和临床医生主导的模组化设计正在重新定义各个外科专科对立体定位设备的期望。

立体定位手术设备融合了精密工程、影像融合和神经外科创新技术。过去十年，导航演算法、微型追踪感测器和机器人辅助技术的进步，重塑了临床医生对手术精确度、术中引导和流程效率的期望。这些设备旨在实现脑部、耳鼻喉和脊椎手术的精准靶点定位，如今，评估这些设备不仅关注其技术性能，还日益重视互通性、消毒便捷性以及对手术室效率的影响。

临床医生和采购负责人现在要求提供证据，证明其具有可重复的准确性，并能切实缩短手术时间和减少併发症。因此，医疗器材的研发优先考虑模组化架构，以便在不中断既定临床通讯协定的情况下逐步升级硬体模组和软体。这促使医院、门诊手术中心和专科诊所重新评估其采购标准，更加重视生命週期灵活性和整体拥有成本。同时，研究机构和临床负责人继续透过多中心研究和註册登记来完善适应症和手术流程的最佳实践。

追踪技术、机器人技术和软体检验工作流程的整合正在推动产品开发和临床应用模式的根本性转变

由于技术、临床和商业性因素的共同作用，立体定位手术器械领域正经历变革性的转变。首先，光学和电磁追踪技术的成熟拓展了无框架手术的应用范围，实现了微创手术流程，并提高了患者的舒适度。同时，机器人辅助技术的兴起带来了致动器精度和外科医生与器械交互方式的新范式，使得讨论的重点从器械的替代转向了手术能力的拓展。

其次，软体定义功能已成为差异化优势。高阶规划套件、即时註册更新和机器辅助轨迹优化正从辅助工具转变为导航生态系统的核心组件。这种转变迫使製造商优先考虑软体检验、使用者介面人体工学和安全的资料架构。第三，医疗设备软体的报销政策和不断变化的监管路径正在影响产品蓝图，并促使企业儘早与支付方和监管机构相关人员沟通。随着这些变化的共同作用，竞争优势如今取决于能否提供端到端的临床价值，这种价值结合了硬体精度、检验的软体以及为医疗服务提供者带来的显着营运效益。

关税驱动的供应链重组和区域製造地转移已经重新定义了2025年的筹资策略和医疗设备设计重点。

2025年美国关税政策为立体定位手术设备及其零件的全球供应链带来了新的贸易摩擦。对精密电子产品、追踪感测器和某些机器人子系统征收的进口关税增加了依赖跨境采购的製造商的成本。为应对这项挑战，多家公司加快了关键供应链的本地化进程，修订了供应商合同，并探索了近岸外包策略，以降低关税波动带来的风险。这些调整导致前置作业时间出现短期中断，并促使采购部门重新评估其库存策略。

面对不断上涨的投入成本，製造商采取了有针对性的策略，将部分成本内部消化，同时透过与高端功能相关的选择性价格调整将其他成本转嫁出去。临床客户和经销商也随之调整，优先采购那些能够带来可衡量的临床效率提升或支援长期服务协议的产品。随着时间的推移，关税主导的趋势促使产品设计创新，减少了对受关税影响部件的依赖，并促进了以区域製造地为中心的伙伴关係，从而保障市场准入并控制营运利润率。因此，如今的策略讨论通常将贸易政策情境作为供应链规划和产品生命週期决策的关键因素。

一个将最终用户、技术、产品、设备类型和临床应用连结起来的多维细分框架揭示了不同临床环境和流程下的独特价值驱动因素。

基于最终用户的细分将医疗机构分为门诊手术中心、医院和专科诊所。门诊手术中心进一步细分为医院附属机构和独立机构，而医院则按私立、公立和教学医院进行分类。这种结构突显了医疗环境对采购週期、资本规划和临床容量需求的影响，并突显了不同机构采用新模式的时间差异。具体而言，独立门诊中心往往优先考虑快速周转率和成本效益，而教学医院则更注重与培训和研究计画的整合。

技术细分将电磁追踪和光学追踪分开，电磁追踪可细分为高频和低频方法，而光学追踪则可分为基于红外线和基于雷射的实现方式。这些技术区别至关重要，因为频率特性、视线限制以及对术中干扰的敏感度决定了特定手术的选择标准。这可以决定医疗机构是选择具有强大且不受视线限制性能的电磁解决方案，还是选择在最佳视线条件下提供高解析度可视化的光学系统。

产品分类包括配件、导航系统和机器人系统。导航系统又细分为硬体模组和软体元件，而机器人系统则分为主动式和被动式架构。硬体模组化和软体功能之间的相互作用决定了升级路径和长期服务关係。同时，主动式和被动式机器人辅助的选择反映了临床理念中关于自动化程度和外科医师控制的重点。

类型分类将系统分为框架系统和无框架系统。有框架系统仅限于立体定位框架，而无框架系统又分为有标记系统和无标记系统。这种分类会影响患者体验和手术物流，因为有框架系统的工作流程需要频繁的术前固定和影像校准，而无框架和无标记系统可以简化患者准备工作，并缩短某些手术的麻醉时间。

应用领域分为神经外科、耳鼻喉科和脊椎外科。神经外科又细分为深部脑部刺激和肿瘤切除术，耳鼻喉科手术细分为鼻窦手术和肿瘤手术，脊椎外科细分为减压术和融合术。这些临床细分决定了不同的器械要求，取决于目标解剖结构、所需的轨迹精度以及术中适应性，进而影响检验研究、外科医生培训计划和上市后证据生成策略。

区域采纳路径反映了美洲、欧洲、中东和非洲以及亚太地区的基础设施成熟度、报销模式和区域证据优先事项。

美洲、欧洲/中东/非洲和亚太地区立体定位手术设备的区域趋势呈现出不同的需求驱动因素，这些因素受到医疗基础设施成熟度、报销标准和当地法规环境的影响。在美洲，大型三级医疗中心和设备创新者的集中推动了先进导航和机器人系统的早期应用，而门诊手术中心则越来越多地采用无框架和无标记解决方案，以支持高通量择期手术。在北美，从研究阶段到常规应用阶段的过渡通常是由可证实的流程效率和与手术报销系统的契合度所驱动的。

在欧洲、中东和非洲地区，不同的监管路径和医院资金筹措模式造就了多样化的应用模式。一些国家强调成本效益高的采购方式，并提供包含培训和长期服务的优质套餐；而领先的追踪技术和机器人混合系统则经常在西欧的卓越医疗中心进行试点。在亚太地区，医院的快速扩张、对诊断成像能力的投资以及不断增强的本地製造能力，正在加速公立和私立医院，特别是教学医院，将立体定向平台整合到不断发展的专科项目中，从而推动相关技术的应用。在所有地区，临床伙伴关係和本地证据的累积仍然是实现持续应用和获得支付方认可的关键。

在竞争激烈的环境中，整合导航生态系统、策略伙伴关係和生命週期服务货币化是设备製造商的关键差异化因素。

立体定位设备领域的主要企业正致力于在硬体、软体和服务这一连续体上进行策略定位，主要企业投资于整合导航生态系统而非独立设备。一些成熟的设备製造商正透过有针对性的收购来扩展其产品组合，从而获得软体规划套件、感测器技术和配套的机器人模组。同时，敏捷的创新者则专注于利用低成本、高精度的追踪技术和创新的无标记配准演算法来实现差异化。这种竞争环境促使人们更加重视软体版本的互通性、合规性以及能够缩短临床医生学习曲线的完善培训计划。

医疗设备製造商、影像供应商和医疗系统之间的合作日益普遍，从而能够共同开发检验的工作流程和进行真实世界证据研究。服务模式正从传统的保固和维护协议演变为与手术结果和运作保证挂钩的价值导向合约。对于新参与企业而言，成功往往取决于在特定应用领域展现出明显的临床优势（例如，深部脑部刺激中的轨迹精度或鼻窦手术中导航时间的缩短），而现有企业则利用规模经济、全球服务网络和已建立的医院关係来保障其现有基本客群的收入来源。投资者和策略伙伴正着眼于软体智慧财产权、感测器融合能​​力和生命週期商业化战略方面的差异化优势。

优先考虑模组化设计、可靠的临床证据、灵活的商业模式和供应链韧性，以推动产品应用并保障长期价值。

产业领导者若想从立体定位手术系统中获取临床和商业性价值，应优先采取一系列切实可行的步骤，使产品开发与临床工作流程和机构采购行为保持一致。首先，投资于模组化架构，以便对硬体模组和软体应用进行增量升级。这使客户能够在引入新功能的同时，保护其现有投资。其次，透过多中心研究，重点在于手术效率、併发症减少和可重复的精确性，从而累积更有力的临床证据。这些数据将有助于采购谈判，并加速临床医生对该系统的应用。第三，发展灵活的商业模式，结合资本投入、订阅和按绩效付费等要素，以适应不同医院和门诊中心的预算。

此外，我们将专注于加强供应链韧性，并透过考虑二级供应商资格和关键零件的区域化生产来规避贸易中断风险。我们将强化上市后支援和培训项目，采用基于模拟的课程体系，以缩短学习曲线并提高手术效率。最后，我们将积极与监管机构和支付方沟通，为软体更新提供清晰的路径，并明确阐述导航式医疗服务的临床和经济价值。透过共同落实这些建议，企业领导者可以最大限度地减少实施阻力，保障利润，并将技术差异化转化为可衡量的临床效益。

临床和营运方面的研究结果透过严格的证据分析检验，该分析整合了临床医生访谈、医疗设备文件、监管记录和技术评估。

该研究结合了对临床医生、采购人员和行业高管的定性访谈，以及对监管申报文件、同行评审的临床研究和产品文献的系统性回顾。主要资讯来源包括与神经外科医生、耳鼻喉科医生、脊椎外科医生和手术室管理人员的半结构化讨论，以了解实际工作流程的限制、推广障碍和所需功能集。次要分析包括设备手册、监管核准和临床试验通讯协定，以检验技术声明并了解证据产生时间表。在整个研究过程中，资讯来源的三角验证确保了报告的临床结果与设备规格之间的一致性。

我们的分析方法结合了访谈记录的主题编码，以识别技术采纳驱动因素，并运用技术评估框架评估追踪准确性、延迟和整合复杂性。供应链分析揭示了贸易政策变化暴露的关键组件依赖关係和物流漏洞。我们仔细交叉引用了公开的监管文件和同行评审的临床文献，以识别证据缺口，并确定未来临床评估的优先领域，同时推荐在医院环境中实施切实可行的检验方法。

整合的临床平台、检验的工作流程和强大的交付策略将决定哪些创新能够转化为持续的临床和商业性成功。

立体定位设备正从独立工具转型为整合式临床平台，这些平台必须具备可验证的手术价值、无缝的互通性以及稳健的供应链策略。技术融合、软体赋能设备监管要求的不断变化以及贸易相关的供应链变革，迫使相关人员在创新与服务、培训和长期升级等实际考虑之间寻求平衡。临床医生越来越倾向于选择能够融入现有影像生态系统并显着降低手术复杂性和变异性的设备。

对于製造商而言，未来的发展方向在于加大对临床证据的投入，制定灵活的商业合同，并加强区域供应链网络以降低政策衝击。对于医疗服务提供者而言，优先考虑生命週期价值和整体工作流程影响而非初始价格来製定采购决策，可以改善患者预后并提高营运效率。简而言之，设备开发商、医疗服务提供者和政策制定者必须携手合作，确保技术进步能够转化为更安全、更便利、更经济高效的立体定位治疗。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧驱动的成像和导航系统整合到立体定位手术中，实现即时手术引导。
  • 开发具有触觉回馈的新一代机械臂，以提高神经外科手术的精确度
  • 推出用于标靶治疗运动障碍和癫痫的微创立体定向平台
  • 新兴的云端基础的数据管理解决方案可用于立体定向手术中的协作规划和结果跟踪
  • MRI相容于立体定位手术器械的广泛应用，使得术中影像诊断成为可能，并提高了手术精确度。
  • 扩增实境与立体定位框架相结合，正越来越多地用于改善神经外科手术中的轨迹可视化。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 立体定位外科器械市场（按最终用户划分）

  • 门诊手术中心
    • 院内门诊手术中心
    • 独立门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
    • 教学医院
  • 专科诊所

第九章 立体定位外科器械市场：依技术划分

  • 电磁追踪
    • 高频
    • 低频
  • 光学追踪
    • 基于红外线的
    • 雷射基座

第十章 立体定位外科器械市场：依产品划分

  • 配件
  • 导航系统
    • 硬体模组
    • 软体
  • 机器人系统
    • 主动系统
    • 被动系统

第十一章 立体定位外科器械市场（按类型划分）

  • 基于框架的设备
    • 立体定位框架
  • 无边框设备
    • 基于标记的
    • 无标记

第十二章 立体定位外科器械市场：依应用领域划分

  • 脑外科手术
    • 深部脑部刺激
    • 肿瘤切除
  • 耳鼻喉科手术
    • 鼻窦手术
    • 肿瘤手术
  • 脊椎手术
    • 减压手术
    • 融合

第十三章 立体定位外科器械市场：按地区划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 立体定位外科器械市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国立体定位外科器械市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Medtronic plc
    • Stryker Corporation
    • Zimmer Biomet Holdings, Inc.
    • Elekta AB（publ）
    • Brainlab AG
    • Renishaw plc
    • Synaptive Medical, Inc.
    • Monteris Medical Corporation
    • iSYS Medizintechnik GmbH
    • FHC, Inc.
Product Code: MRR-DD0700E81DCF

The Stereotactic Surgery Devices Market is projected to grow by USD 40.65 billion at a CAGR of 5.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 26.47 billion
Estimated Year [2025] USD 27.96 billion
Forecast Year [2032] USD 40.65 billion
CAGR (%) 5.50%

High-precision navigation, integrated imaging workflows, and clinician-driven modularity are redefining expectations for stereotactic surgery devices across surgical specialties

Stereotactic surgery devices are at the intersection of precision engineering, imaging integration, and neurosurgical innovation. Over the last decade, advances in navigation algorithms, miniaturized tracking sensors, and robotic assistance have reshaped clinician expectations for accuracy, intraoperative guidance, and workflow efficiency. These devices, designed to enable precise target localization for interventions in the brain, ear, nose and throat, and spine, are increasingly evaluated not only on technical performance but also on interoperability with existing imaging platforms, ease of sterilization, and throughput implications for operating room schedules.

Clinicians and procurement leaders now demand evidence of reproducible accuracy and demonstrable reductions in procedure time and complications. Consequently, device development has prioritized modular architectures that allow incremental upgrades to hardware modules and software without disrupting established clinical protocols. As a result, hospitals, ambulatory surgical centers, and specialty clinics are reconsidering procurement criteria to emphasize lifecycle flexibility and total cost of ownership, while research institutions and clinical leaders continue to refine indications and procedural best practices through multi-center collaborations and registries.

Convergence of tracking, robotics, and software-validated workflows is driving a fundamental reorientation of product development and clinical adoption patterns

The landscape of stereotactic surgery devices is undergoing transformative shifts driven by converging technological, clinical, and commercial forces. First, the maturation of optical and electromagnetic tracking technologies has expanded the procedural envelope for frameless approaches, enabling less invasive workflows and improved patient comfort. Simultaneously, the rise of robotic assistance has introduced new paradigms in actuator precision and surgeon-device collaboration, shifting the conversation from device replacement to augmentation of surgical capability.

Second, software-defined functionality has become a differentiator. Advanced planning suites, real-time registration updates, and machine-assisted trajectory optimization are migrating from adjunct tools to core components of navigation ecosystems. This transition compels manufacturers to prioritize software validation, user interface ergonomics, and secure data architectures. Third, reimbursement policies and evolving regulatory pathways for software as a medical device are influencing product roadmaps, prompting earlier stakeholder engagement with payers and regulators. Together, these shifts mean that competitive advantage now resides in the ability to deliver end-to-end clinical value-combining hardware precision, validated software, and clear operational benefits for care providers.

Tariff-induced supply chain recalibrations and regional manufacturing shifts reshaped procurement strategies and device design priorities throughout 2025

The imposition of tariffs in the United States during 2025 introduced a layer of trade friction that affected the global supply chain for stereotactic surgery devices and their subcomponents. Import duties on precision electronics, tracking sensors, and certain robotic subsystems increased costs for manufacturers who relied on cross-border component sourcing. In response, several firms accelerated localization of critical supply lines, re-evaluated supplier contracts, and explored nearshoring strategies to mitigate exposure to tariff volatility. These adjustments triggered short-term disruptions in lead times and prompted a reassessment of inventory strategies within procurement organizations.

Manufacturers facing higher input costs made targeted decisions to absorb some expenses while passing others through in the form of selective price adjustments tied to premium feature sets. Clinical customers and distributors adapted by prioritizing purchases that delivered measurable clinical efficiencies or that supported long-term service agreements. Over time, the tariff-driven dynamics spurred innovation in product design to reduce reliance on tariffed components, and they incentivized partnerships focused on regional manufacturing hubs to protect access and control operating margins. As a consequence, strategy conversations now routinely include trade policy scenarios as a material factor in supply chain planning and product lifecycle decisions.

A multidimensional segmentation framework linking end user, technology, product, device type, and clinical application reveals differentiated value drivers across care settings and procedures

Segmentation based on end user distinguishes ambulatory surgical centers, hospitals, and specialty clinics, with ambulatory surgical centers further parsed into hospital-based and independent facilities, and hospitals differentiated across private, public, and teaching institutions; this structure highlights how care setting influences procurement cycles, capital planning, and clinical throughput imperatives, revealing divergent adoption timelines where independent ambulatory centers often prioritize rapid turnover and cost efficiency while teaching hospitals emphasize integration with training and research programs.

Technology segmentation separates electromagnetic tracking and optical tracking, with electromagnetic tracking subdivided into high frequency and low frequency approaches and optical tracking distinguished by infrared-based and laser-based implementations; these technological delineations matter because frequency characteristics, line-of-sight limitations, and susceptibility to intraoperative interference drive selection criteria for specific procedures, influencing whether a facility opts for an electromagnetic solution with robust line-insensitive performance or an optical system that offers high-resolution visualization under optimal sightlines.

Product segmentation groups accessories, navigation systems, and robotic systems, where navigation systems break down into hardware modules and software components and robotic systems split into active and passive architectures; the interplay between hardware modularity and software capabilities determines upgrade pathways and long-term service relationships, while the choice between active and passive robotic assistance reflects clinical philosophy regarding the degree of automation and surgeon control.

Type segmentation contrasts frame-based and frameless devices, with frame-based devices narrowed to stereotactic frames and frameless devices categorized into marker-based and markerless approaches; this typology matters for patient experience and procedural logistics because frame-based workflows often involve preoperative fixation and imaging coordination, whereas frameless markerless systems streamline patient preparation and can reduce anesthesia time in selected procedures.

Application segmentation includes brain surgery, ENT surgery, and spine surgery, with brain procedures further classified into deep brain stimulation and tumor resection, ENT procedures into sinus surgery and tumor surgery, and spine procedures into decompression and fusion; these clinical subdivisions underscore how device requirements vary by target anatomy, required trajectory precision, and the need for intraoperative adaptability, which in turn shapes validation studies, surgeon training programs, and post-market evidence generation strategies.

Distinct regional adoption pathways reflect infrastructure maturity, reimbursement paradigms, and localized evidence generation priorities across the Americas, EMEA, and Asia-Pacific

Regional dynamics for stereotactic surgery devices show distinct demand drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each shaped by healthcare infrastructure maturity, reimbursement norms, and local regulatory environments. In the Americas, large tertiary centers and a high concentration of device innovators drive early adoption of advanced navigation and robotic systems, while ambulatory surgical centers expand uptake of frameless and markerless solutions that support high-throughput elective procedures. Transitioning from research to routine use in North America often hinges on demonstrable workflow efficiencies and alignment with procedural reimbursement.

In Europe, Middle East & Africa, heterogeneous regulatory pathways and varied hospital funding models create a mosaic of adoption patterns; several nations emphasize cost-conscious procurement and high-value bundles that include training and long-term service, whereas centers of excellence in Western Europe often pilot cutting-edge tracking and robotic hybrids. In the Asia-Pacific region, rapid hospital expansion, investment in diagnostic imaging capacity, and growing local manufacturing capabilities have accelerated adoption across both private and public hospital segments, with particular momentum in teaching hospitals that integrate stereotactic platforms into specialty program growth. Across all regions, clinical partnerships and localized evidence generation remain central to unlocking durable adoption and payer acceptance.

Competitive dynamics favor integrated navigation ecosystems, strategic partnerships, and lifecycle service monetization as core differentiators for device companies

Key company dynamics in the stereotactic devices arena center on strategic positioning along the hardware-software-service continuum, with leading firms investing in integrated navigation ecosystems rather than standalone instruments. Several incumbent device manufacturers have expanded portfolios through targeted acquisitions that add software planning suites, sensor technologies, or complementary robotic modules, while nimble innovators have focused on niche differentiation through lower-cost, high-precision tracking or novel markerless registration algorithms. This competitive mix intensifies emphasis on interoperability, regulatory compliance for software releases, and robust training programs to shorten clinician learning curves.

Partnerships between device makers, imaging vendors, and health systems are increasingly common, enabling co-development of validated workflows and real-world evidence studies. Service models are evolving from traditional warranty and maintenance contracts toward value-based agreements tied to procedural outcomes and uptime guarantees. For new entrants, success frequently depends on demonstrating clear clinical advantages in specific applications-such as deep brain stimulation trajectory accuracy or sinus surgery navigation time reduction-while incumbents leverage scale, global service networks, and established hospital relationships to protect installed-base revenue streams. Investors and strategic partners are watching closely for differentiators in software intellectual property, sensor fusion capabilities, and lifecycle monetization strategies.

Prioritize modular design, robust clinical evidence, flexible commercial models, and supply chain resilience to accelerate adoption and protect long-term value

Industry leaders seeking to capture clinical and commercial value from stereotactic surgery devices should prioritize a set of actionable moves that align product development with clinical workflows and institutional buying behavior. First, invest in modular architectures that allow incremental upgrades to hardware modules and software applications, enabling customers to protect prior investments while adopting new capabilities. Second, build stronger clinical evidence through multi-center studies that emphasize procedural efficiency, complication reduction, and reproducible accuracy; such data support procurement discussions and accelerate clinician acceptance. Third, develop flexible commercial models that combine capital, subscription, and outcomes-linked service components to address diverse hospital and ambulatory center budgets.

Additionally, focus on supply chain resilience by qualifying secondary suppliers for critical components and exploring regional manufacturing to hedge against trade disruptions. Strengthen post-market support and training programs with simulation-based curricula that shorten the learning curve and increase procedural throughput. Finally, proactively engage with regulators and payers to clarify pathways for software updates and to articulate the clinical and economic value of navigation-enabled care. Executed together, these recommendations will help leaders minimize adoption friction, protect margins, and translate technical differentiation into measurable clinical impact.

A rigorous evidence synthesis combining clinician interviews, device documentation, regulatory records, and technology assessments to validate clinical and operational insights

This research synthesizes primary qualitative interviews with clinicians, procurement leaders, and industry executives alongside a structured review of regulatory filings, peer-reviewed clinical studies, and product literature. Primary inputs included semi-structured discussions with neurosurgeons, ENT specialists, spine surgeons, and operating room managers to capture real-world workflow constraints, adoption inhibitors, and desired feature sets. Secondary analysis encompassed device manuals, regulatory approvals, and clinical trial protocols to verify technical claims and to understand evidence generation timelines. Throughout the research, source triangulation ensured consistency between reported clinical outcomes and device specifications.

Analytical methods combined thematic coding of interview transcripts to identify recurring adoption drivers with technology assessment frameworks that evaluated tracking accuracy, latency, and integration complexity. Supply chain analysis mapped critical component dependencies and logistics vulnerabilities exposed by trade policy changes. Care was taken to verify factual assertions against publicly available regulatory documents and peer-reviewed clinical literature. Where gaps in evidence existed, the analysis identified priority areas for future clinical evaluation and recommended approaches for pragmatic validation within hospital settings.

Integrated clinical platforms, validated workflows, and resilient supply strategies will determine which innovations translate into sustained clinical and commercial success

Stereotactic surgery devices are transitioning from discrete tools to integrated clinical platforms that must deliver demonstrable procedural value, seamless interoperability, and resilient supply strategies. The combined forces of technological convergence, evolving regulatory expectations for software-enabled devices, and trade-related supply chain shifts mean that stakeholders must balance innovation with practical considerations around service, training, and long-term upgradeability. Clinicians increasingly seek devices that integrate into established imaging ecosystems and that provide clear reductions in procedure complexity and variability.

For manufacturers, the path ahead requires investing in clinical evidence, building flexible commercial arrangements, and strengthening regional supply networks to mitigate policy-driven disruptions. For providers, prioritizing procurement decisions based on lifecycle value and total workflow impact rather than initial acquisition price will improve patient outcomes and operational efficiency. In sum, the community of device developers, healthcare providers, and policy makers must collaborate to ensure that technological advances translate into safer, more accessible, and more cost-effective stereotactic care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven imaging and navigation systems for real-time surgical guidance in stereotactic procedures
  • 5.2. Development of next-generation robotic arms with haptic feedback to enhance precision in neurosurgical interventions
  • 5.3. Adoption of minimally invasive stereotactic platforms for targeted treatment of movement disorders and epilepsy
  • 5.4. Emergence of cloud-based data management solutions for collaborative planning and outcome tracking in stereotactic surgery
  • 5.5. Expansion of MRI-compatible stereotactic instruments enabling intraoperative imaging for improved surgical accuracy
  • 5.6. Growing use of augmented reality overlays integrated with stereotactic frames for enhanced trajectory visualization during brain surgery

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stereotactic Surgery Devices Market, by End User

  • 8.1. Ambulatory Surgical Centers
    • 8.1.1. Hospital-Based Ascs
    • 8.1.2. Independent Ascs
  • 8.2. Hospitals
    • 8.2.1. Private Hospitals
    • 8.2.2. Public Hospitals
    • 8.2.3. Teaching Hospitals
  • 8.3. Specialty Clinics

9. Stereotactic Surgery Devices Market, by Technology

  • 9.1. Electromagnetic Tracking
    • 9.1.1. High Frequency
    • 9.1.2. Low Frequency
  • 9.2. Optical Tracking
    • 9.2.1. Infrared Based
    • 9.2.2. Laser Based

10. Stereotactic Surgery Devices Market, by Product

  • 10.1. Accessories
  • 10.2. Navigation Systems
    • 10.2.1. Hardware Modules
    • 10.2.2. Software
  • 10.3. Robotic Systems
    • 10.3.1. Active Systems
    • 10.3.2. Passive Systems

11. Stereotactic Surgery Devices Market, by Type

  • 11.1. Frame Based Devices
    • 11.1.1. Stereotactic Frames
  • 11.2. Frameless Devices
    • 11.2.1. Marker Based
    • 11.2.2. Markerless

12. Stereotactic Surgery Devices Market, by Application

  • 12.1. Brain Surgery
    • 12.1.1. Deep Brain Stimulation
    • 12.1.2. Tumor Resection
  • 12.2. Ent Surgery
    • 12.2.1. Sinus Surgery
    • 12.2.2. Tumor Surgery
  • 12.3. Spine Surgery
    • 12.3.1. Decompression
    • 12.3.2. Fusion

13. Stereotactic Surgery Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stereotactic Surgery Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stereotactic Surgery Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Medtronic plc
    • 16.3.2. Stryker Corporation
    • 16.3.3. Zimmer Biomet Holdings, Inc.
    • 16.3.4. Elekta AB (publ)
    • 16.3.5. Brainlab AG
    • 16.3.6. Renishaw plc
    • 16.3.7. Synaptive Medical, Inc.
    • 16.3.8. Monteris Medical Corporation
    • 16.3.9. iSYS Medizintechnik GmbH
    • 16.3.10. FHC, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. STEREOTACTIC SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. STEREOTACTIC SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. STEREOTACTIC SURGERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITAL-BASED ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INDEPENDENT ASCS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HIGH FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LOW FREQUENCY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY INFRARED BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY LASER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HARDWARE MODULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ACTIVE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PASSIVE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY STEREOTACTIC FRAMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKER BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY MARKERLESS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SINUS SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TUMOR SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY DECOMPRESSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPTICAL TRACKING, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY NAVIGATION SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ROBOTIC SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAME BASED DEVICES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY FRAMELESS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY BRAIN SURGERY, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ENT SURGERY, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY SPINE SURGERY, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY ELECTROMAGNETIC TRACKING, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA STEREOTACTIC SURGERY DEVICES MARKET SIZE, BY OPT